TipRanks
Go Ultimate55% OFF

Immunic (IMUX) Income Statement

Immunic Income Statement

Last quarter (Q2 2026), Immunic's total revenue was $0.00. In Q2, Immunic's net income was $-34.10M. See Immunic’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 103.23M$ 98.05M$ 99.22M$ 119.49M$ 91.67M
Depreciation and Amortization$ 168.00K$ 134.00K$ 111.00K$ 77.00K$ 85.00K
$ -97.00M$ -100.37M$ -93.50M$ -86.44M$ -92.86M
$ -103.23M$ -98.05M$ -99.22M$ -119.49M$ -91.67M
$ 6.06M$ -2.46M$ 5.61M$ -919.00K$ -1.28M
$ -97.17M$ -100.51M$ -93.61M$ -120.41M$ -92.94M
$ -97.17M$ -100.51M$ -93.61M$ -120.41M$ -92.94M
Per Share Metrics
Basic EPS$ -6.24$ -10.03$ -21.12$ -37.84$ -39.30
Diluted EPS$ -6.24$ -10.03$ -21.12$ -37.84$ -39.30
Weighted Average Shares Outstanding15.57M10.02M4.43M3.18M2.37M
Weighted Average Shares Outstanding (Diluted)15.57M10.02M4.43M3.18M2.37M

Currency in USD

Immunic Earnings and Revenue History

-150M-100M-50M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin